Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated With Favorable Outcomes In Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial (Alliance)
- Citation:
- Blood vol 144 (Supplement 1) 224
- Meeting Instance:
- ASH 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Meagan A. Jacoby David H. Spencer Geoffrey L. Uy Feng Gao Tasha Burton Sharon E. Heath Feiyu Du Michelle O'Laughlin Robert S. Fulton Zeina A. Al-Mansour Christopher R. Cogle Eric J. Huselton John F. DiPersio Peter Westervelt Mark A. Schroeder Armin Ghobadi Iskra Pusic Keith E. Stockerl-Goldstein Brad S. Kahl Amanda F. Cashen Matthew J. Christopher Nathan Singh Ravi Vij Zachary D. Crees Ryan B. Day Todd A. Fehniger Karolyn A.Oetjen Dilan A. Patel Miriam Y. Kim Michael J. Slade Daniel C. Link Matthew J. Walter Camille N. Abboud Ramzi Abboud Timothy J. Ley
- Networks:
- LAPS-MO011, MA011, MAINE
- Study
- Alliance-A152322
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-10201, CALGB-19808, CALGB-8525, CALGB-8923, CALGB-9420, CALGB-9621, CALGB-9720
- Phases:
- N/A, 1, 3
- Keywords: